Loading...
1388 logo

Embry Holdings LimitedSEHK:1388 Stock Report

Market Cap HK$104.3m
Share Price
n/a
1Y-44.5%
7D-8.5%
1D-5.0%
Portfolio Value
​
View

Embry Holdings Limited

SEHK:1388 Stock Report

Market Cap: HK$104.3m

Embry Holdings (1388) Stock Overview

An investment holding company, designs, research, develops, manufactures, trades in, and sells ladies lingerie, brassieres, panties, swimwear, sleepwear, and others in Chinese Mainland, Hong Kong, and internationally. More details

1388 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Risk Analysis

Earnings have declined by 60.5% per year over past 5 years

Does not have a meaningful market cap (HK$104M)


1388 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,394 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
479,394 investors already sharing narratives
View all narratives

Embry Holdings Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Embry Holdings
Historical stock prices
Current Share PriceHK$0.25
52 Week HighHK$0.49
52 Week LowHK$0.24
Beta0.31
1 Month Change-10.18%
3 Month Change-20.32%
1 Year Change-44.49%
3 Year Change-50.10%
5 Year Change-76.92%
Change since IPO-95.16%

Recent News & Updates

Recent updates

Analysis Article • May 22

Embry Holdings Limited's (HKG:1388) CEO Might Not Expect Shareholders To Be So Generous This Year

Key Insights Embry Holdings to hold its Annual General Meeting on 29th of May CEO Liza Cheng's total compensation...
Analysis Article • Feb 17

Embry Holdings Limited (HKG:1388) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Embry Holdings Limited ( HKG:1388 ) shareholders have had their patience rewarded with a 27% share price jump in the...
Analysis Article • Dec 04

Health Check: How Prudently Does Embry Holdings (HKG:1388) Use Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Oct 02

Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price

When you see that almost half of the companies in the Luxury industry in Hong Kong have price-to-sales ratios (or...
Analysis Article • Feb 06

Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet

You may think that with a price-to-sales (or "P/S") ratio of 0.1x Embry Holdings Limited ( HKG:1388 ) is a stock worth...
Analysis Article • Sep 30

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jul 20

Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
Analysis Article • Mar 21

Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?

Could Embry Holdings Limited ( HKG:1388 ) be an attractive dividend share to own for the long haul? Investors are often...
Analysis Article • Feb 21

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
Analysis Article • Dec 19

Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?

We think intelligent long term investing is the way to go. But no-one is immune from buying too high. For example...
Analysis Article • Nov 23

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...

Shareholder Returns

1388HK LuxuryHK Market
7D-8.5%-2.4%-1.3%
1Y-44.5%-19.3%-5.8%

Return vs Industry: 1388 underperformed the Hong Kong Luxury industry which returned -19.3% over the past year.

Return vs Market: 1388 underperformed the Hong Kong Market which returned -5.8% over the past year.

Price Volatility

Is 1388's price volatile compared to industry and market?
1388 volatility
1388 Average Weekly Movement5.6%
Luxury Industry Average Movement6.5%
Market Average Movement7.8%
10% most volatile stocks in HK Market16.0%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1388 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1388's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19753,719Liza Chengwww.embrygroup.com

Embry Holdings Limited, an investment holding company, designs, research, develops, manufactures, trades in, and sells ladies lingerie, brassieres, panties, swimwear, sleepwear, and others in Chinese Mainland, Hong Kong, and internationally. The company sells its lingerie products primarily under the EMBRY FORM, FANDECIE, COMFIT, E-BRA, IVU, IADORE, EMBRYKIDS, and LIZA CHENG brands. It also holds trademark and invests in properties.

Embry Holdings Limited Fundamentals Summary

How do Embry Holdings's earnings and revenue compare to its market cap?
1388 fundamental statistics
Market capHK$104.34m
Earnings (TTM)-HK$253.18m
Revenue (TTM)HK$1.17b
0.1x
P/S Ratio
-0.4x
P/E Ratio

Is 1388 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1388 income statement (TTM)
RevenueHK$1.17b
Cost of RevenueHK$351.53m
Gross ProfitHK$818.45m
Other ExpensesHK$1.07b
Earnings-HK$253.18m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Aug 28, 2026

Earnings per share (EPS)-0.60
Gross Margin69.95%
Net Profit Margin-21.64%
Debt/Equity Ratio28.0%

How did 1388 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/17 02:13
End of Day Share Price 2026/08/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Embry Holdings Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mandy ShekCGS International
Shadow LAUMaybank Research Pte. Ltd.
Larry ChoYuanta Research